Changing gears in Nrf1 research, from mechanisms of regulation to its role in disease and prevention

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1849, Issue 10, 2015, Pages 1260-1276

  Bugno, Magdalena ^a   Daniel, Mary ^a   Chepelev, Nikolai L ^a   Willmore, William G ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

Disease; Function; NFE2L1; Nrf1; Regulation; Structure

Indexed keywords

AMINO ACID; CASEIN KINASE II; DNA; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEASOME; TRANSCRIPTION FACTOR NRF1; TRANSCRIPTION FACTOR NRF2; GLUCOSE; NRF1 PROTEIN, HUMAN; NUCLEAR RESPIRATORY FACTOR 1;

ALTERNATIVE RNA SPLICING; DEGLYCOSYLATION; DIABETES MELLITUS; DNA BINDING; FATTY LIVER; GENE CONTROL; GENETIC STABILITY; GLUCONEOGENESIS; GLUCOSE TRANSPORT; GLYCOLYSIS; HALF LIFE TIME; HEK293 CELL LINE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIVER DEVELOPMENT; NERVE DEGENERATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; TRANSACTIVATION; UBIQUITINATION; CITRIC ACID CYCLE; GENETICS; GLYCOSYLATION; METABOLISM; PROTEIN DEGRADATION;

AMINO ACIDS; CITRIC ACID CYCLE; DIABETES MELLITUS; GLUCOSE; GLYCOSYLATION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; NUCLEAR RESPIRATORY FACTOR 1; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS;

EID: 84940118739     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2015.08.001     Document Type: Review

References (145)

1. Bowerman B., Draper B.W., Mello C.C., Priess J.R. The maternal gene skn-1 encodes a protein that is distributed unequally in early C. elegans embryos. Cell 1993, 74:443-452.
2. Bowerman B., Eaton B.A., Priess J.R. Skn-1, a maternally expressed gene required to specify the fate of ventral blastomeres in the early C. elegans embryo. Cell 1992, 68:1061-1075.
3. Mohler J., Mahaffey J.W., Deutsch E., Vani K. Control of Drosophila head segment identity by the bZIP homeotic gene cnc. Development 1995, 121:237-247.
4. Mohler J., Vani K., Leung S., Epstein A. Segmentally restricted, cephalic expression of a leucine zipper gene during Drosophila embryogenesis. Mech. Dev. 1991, 34:3-9.
5. Chan J.Y., Han X.L., Kan Y.W. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:11371-11375.
6. Johnsen O., Skammelsrud N., Luna L., Nishizawa M., Prydz H., Kolstø A.B. Small Maf proteins interact with the human transcription factor TCF11/Nrf1/LCR-F1. Nucleic Acids Res. 1996, 24:4289-4297.
7. Kobayashi A., Yamagiwa H., Hoshino H., Muto A., Sato K., Morita M., Hayashi N., Yamamoto M., Igarashi K. A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR through the BTB/POZ domain. Mol. Cell. Biol. 1999, 20:1733-1746.
8. Farmer S.C., Sun C.W., Winnier G.E., Hogan B.L., Townes T.M. The bZIP transcription factor LCR-F1 is essential for mesoderm formation in mouse development. Genes Dev. 1997, 11:786-798.
9. Caterina J.J., Donze D., Sun C.W., Ciavatta D.J., Townes T.M. Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression. Nucleic Acids Res. 1994, 22:2383-2391.
10. Andrews N.C., Erdjument-Bromage H., Davidson M.B., Tempst P., Orkin S.H. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature 1993, 362:722-728.
11. Chan J.Y., Han X.L., Kan Y.W. Isolation of cDNA encoding the human NF-E2 protein. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:11366-11370.
12. Zhang Y., Ren Y., Li S., Hayes J.D. Transcription factor Nrf1 is topologically repartitioned across membranes to enable target gene transactivation through its acidic glucose-responsive domains. PLoS ONE 2014, 9:e93458.
13. Zhang Y., Lucocq J.M., Yamamoto M., Hayes J.D. The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation. Biochem. J. 2007, 408:161-172.
14. Zhang Y., Hayes J.D. The membrane-topogenic vectorial behaviour of Nrf1 controls its post-translational modification and transactivation activity. Sci. Rep. 2013, 3:2006.
15. Moi P., Chan K., Asunis I., Cao A., Kan Y.W. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:9926-9930.
16. Kobayashi A., Ito E., Toki T., Kogame K., Takahashi S., Igarashi K., Hayashi N., Yamamoto M. Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J. Biol. Chem. 1999, 274:6443-6452.
17. Chénais B., Derjuga A., Massrieh W., Red-Horse K., Bellingard V., Fisher S.J., Blank V. Functional and placental expression analysis of the human NRF3 transcription factor. Mol. Endocrinol. 2005, 19:125-137.
18. Chevillard G., Blank V. NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors. Cell. Mol. Life Sci. 2011, 68:3337-3348.
19. Blouin J.L., Duriaux Saïl G., Guipponi M., Rossier C., Pappasavas M.P., Antonarakis S.E. Isolation of the human BACH1 transcription regulator gene, which maps to chromosome 21q22.1. Hum. Genet. 1998, 102:282-288.
20. Ohira M., Seki N., Nagase T., Ishikawa K., Nomura N., Ohara Characterization of a human homolog (BACH1) of the mouse Bach1 gene encoding a BTB-basic leucine zipper transcription factor and its mapping to chromosome 21q22.1. Genomics 1998, 47:300-306.
21. Muto A., Hoshino H., Madisen L., Yanai N., Obinata M., Karasuyama H., Hayashi N., Nakauchi H., Yamamoto M., Groudine M., Igarashi K. Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 39 enhancer. EMBO J. 1998, 17:5734-5743.
22. Sasaki S., Ito E., Toki T., Maekawa T., Kanezaki R., Umenai T., Muto A., Nagai H., Kinoshita T., Yamamoto M., Inazawa J., Taketo M.M., Nakahata T., Igarashi K., Yokoyama M. Cloning and expression of human B cell-specific transcription factor BACH2 mapped to chromosome 6q15. Oncogene 2000, 19:3739-3749.
23. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 1991, 266:11632-11639.
24. Primiano T., Sutter T.R., Kensler T.W. Antioxidant-inducible genes. Adv. Pharmacol. 1997, 38:293-328.
25. Primiano T., Li Y., Kensler T.W., Trush M.A., Sutter T.R. Identification of dithiolethione-inducible gene-1 as a leukotriene B412-hydroxydehydrogenase: implications for chemoprevention. Carcinogenesis 1998, 19:999-1005.
26. Ishii T., Itoh K., Akasaka J., Yanagawa T., Takahashi S., Yoshida H., Bannai S., Yamamoto M. Induction of murine intestinal and hepatic peroxiredoxin MSP23 by dietary butylated hydroxyanisole. Carcinogenesis 2000, 21:1013-1016.
27. Chen L., Kwong M., Lu R., Ginzinger D., Lee C., Leung L., Chan J.Y. Nrf1 is critical for redox balance and survival of liver cells during development. Mol. Cell. Biol. 2003, 23:4673-4686.
28. Leung L., Kwong M., Hou S., Lee C., Chan J.Y. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J. Biol. Chem. 2003, 278:48021-48029.
29. Yang H., Magilnick N., Lee C., Kalmaz D., Ou X., Chan J.Y., Lu S.C. Nrf1 and Nrf2 regulate rat glutamate-cysteine ligase catalytic subunit transcription indirectly via NF-κB and AP-1. Mol. Cell. Biol. 2005, 25:5933-5946.
30. McMahon M., Itoh K., Yamamoto M., Chanas S.A., Henderson C.J., McLellan L.I., Wolf C.R., Cavin C., Hayes J.D. The Cap 'n' Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 2001, 61:3299-3307.
31. Chanas S.A., Jiang Q., McMahon M., McWalter G.K., McLellan L.I., Elcombe C.R., Henderson C.J., Wolf C.R., Moffat G.J., Itoh K., Yamamoto M., Hayes J.D. Loss of the Nrf2 transcription factor causes a marked reduction in constitutive and inducible expression of the glutathione S-transferase Gsta1, Gsta2, Gstm1, Gstm2, Gstm3 and Gstm4 genes in the livers of male and female mice. Biochem. J. 2002, 365:405-416.
32. Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007, 47:89-116.
33. Ohtsuji M., Katsuoka F., Kobayashi A., Aburatani H., Hayes J.D., Yamamoto M. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J. Biol. Chem. 2008, 283:33554-33562.
34. Biswas M., Chan J.Y. Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol. Appl. Pharmacol. 2010, 244:16-20.
35. Jaiswal A.K. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic. Biol. Med. 2004, 36:1199-1207.
36. Sykiotis G.P., Bohmann D. Stress-activated cap'n'collar transcription factors in aging and human disease. Sci. Signal. 2010, 3:re3.
37. Taguchi K., Motohashi H., Yamamoto M. Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution. Genes Cells 2011, 16:123-140.
38. Kansanen E., Kuosmanen S.M., Leinonen H., Levonen A.L. The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer. Redox Biol. 2013, 1:45-49.
39. Uruno A., Yagishita Y., Yamamoto M. The Keap1-Nrf2 system and diabetes mellitus. Arch. Biochem. Biophys. 2015, 566:76-84.
40. He X., Ma Q. NRF2 cysteine residues are critical for oxidant/electrophile-sensing, Kelch-like ECH-associated protein-1-dependent ubiquitination-proteasomal degradation, and transcription activation. Mol. Pharmacol. 2009, 76:1265-1278.
41. Hayes J.D., Dinkova-Kostova A.T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 2014, 39:199-218.
42. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 2011, 85:241-272.
43. Tsujita T., Peirce V., Baird L., Matsuyama Y., Takaku M., Walsh S.V., Griffin J.L., Uruno A., Yamamoto M., Hayes J.D. Transcription factor Nrf1 negatively regulates the cystine/glutamate transporter and lipid-metabolizing enzymes. Mol. Cell. Biol. 2014, 34:3800-3816.
44. Zhang Y., Lucocq J.M., Hayes J.D. The Nrf1 CNC/bZIP protein is a nuclear envelope-bound transcription factor that is activated by t-butyl hydroquinone but not by endoplasmic reticulum stressors. Biochem. J. 2009, 418:293-310.
45. Zhang J., Hosoya T., Maruyama A., Nishikawa K., Maher J.M., Ohta T., Motohashi H., Fukamizu A., Shibahara S., Itoh K., Yamamoto M. Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes. Biochem. J. 2007, 404:459-466.
46. Zhang Y., Qiu L., Li S., Xiang Y., Chen J., Ren Y. The C-terminal domain of Nrf1 negatively regulates the full-length CNC-bZIP factor and its shorter isoform LCR-F1/Nrf1β; both are also inhibited by the small dominant-negative Nrf1γ/δ isoforms that down-regulate ARE-battery gene expression. PLoS ONE 2014, 9:e109159.
47. Zhao R., Hou Y., Xue P., Woods C.G., Fu J., Feng B., Guan D., Sun G., Chan J.Y., Waalkes M.P., Andersen M.E., Pi J. Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ. Health Perspect. 2010, 119:56-62.
48. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10:549-557.
49. Okawa H., Motohashi H., Kobayashi A., Aburatani H., Kensler T.W., Yamamoto M. Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochem. Biophys. Res. Commun. 2006, 339:79-88.
50. Yates M.S., Tran Q.T., Dolan P.M., Osburn W.O., Shin S., McCulloch C.C., Silkworth J.B., Taguchi K., Yamamoto M., Williams C.R., Liby K.T., Sporn M.B., Sutte T.R., Kensler T.W. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 2009, 30:1024-1031.
51. Wang W., Kwok A.M., Chan J.Y. The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription. J Biol. Chem. 2007, 282:24670-24678.
52. Zhang Y., Crouch D.H., Yamamoto M., Hayes J.D. Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum. Biochem. J. 2006, 399:373-385.
53. Kobayashi A., Ohta T., Yamamoto M. Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods Enzymol. 2004, 378:273-286.
54. Wang W., Chan J.Y. Nrf1 is targeted to the endoplasmic reticulum membrane by an N-terminal transmembrane domain. Inhibition of nuclear translocation and transacting function. J. Biol. Chem. 2006, 281:19676-19687.
55. Radhakrishnan S.K., den Besten W., Deshaies R.J. p97-dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition. Elife 2014, 3:e01856.
56. Sha Z., Goldberg A.L. Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97. Curr. Biol. 2014, 24:1573-1583.
57. Husberg C., Murphy P., Martin E., Kolsto A.B. Two domains of the human bZIP transcription factor TCF11 are necessary for transactivation. J. Biol. Chem. 2001, 276:17641-17652.
58. McKie J., Johnstone K., Mattei M.G., Scambler P. Cloning and mapping of murine Nfe2l1. Genomics 1995, 25:716-719.
59. Haze K., Yoshida H., Yanagi H., Yura T., Mori K. Mammalian transcription factor ATF6 is synthesized as a transmembrane protein and activated by proteolysis in response to endoplasmic reticulum stress. Mol. Biol. Cell 1999, 10:3787-3799.
60. Biswas M., Phan D., Watanabe M., Chan J.Y. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis. J. Biol. Chem. 2011, 286:39282-39289.
61. Zhang Y., Yonggang R., Shaojun L., Hayes J.D. Transcription factor Nrf1 is topologically repartitioned across membranes to enable target gene transactivation through its acidic glucose-responsive domains. PLoS ONE 2014, e93458.
62. Tsuchiya Y., Morita T., Kim M., Iemura S., Natsume T., Yamamoto M., Kobayashi A. Dual regulation of the transcriptional activity of Nrf1 by β-TrCP- and Hrd1-dependent degradation mechanisms. Mol. Cell. Biol. 2011, 31:4500-4512.
63. Chowdhry S., Zhang Y., McMahon M., Sutherland C., Cuadrado A., Hayes J.D. Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 2013, 32:3765-3781.
64. Luna L., Johnsen O., Skartlien A.H., Pedeutour F., Turc-Carel C., Prydz H., Kolstø A.B. Molecular cloning of a putative novel human bZIP transcription factor on chromosome 17q22. Genomics 1994, 22:553-562.
65. Itoh K., Igarashi K., Hayashi N., Nishizawa M., Yamamoto M. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol. Cell. Biol. 1995, 15:4184-4193.
66. Xing W., Singgih A., Kapoor A., Alarcon C.M., Baylink D.J., Mohan S. Nuclear factor-E2-related factor-1 mediates ascorbic acid induction of osterix expression via interaction with antioxidant-responsive element in bone cells. J. Biol. Chem. 2007, 282:22052-22061.
67. Inoue K., Imai Y. Identification of novel transcription factors in osteoclast differentiation using genome-wide analysis of open chromatin determined by DNase-seq. J. Bone Miner. Res. 2014, 1823-1832.
68. Pi J., Leung L., Xue P., Wang W., Hou Y., Liu D., Yehuda-Shnaidman E., Lee C., Lau J., Kurtz T.W., Chan J.Y. Deficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesity. J. Biol. Chem. 2010, 285:9292-9300.
69. Schneider K.S., Chan J.Y. Emerging role of Nrf2 in adipocytes and adipose biology. Adv. Nutr. 2013, 4:62-66.
70. Andrews N.C. Molecules in focus: the NF-E2 transcription factor. Int. J. Biochem. Cell Biol. 1998, 30:429-432.
71. Johnsen O., Murphy P., Prydz H., Kolsto A.B. Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res. 1998, 26:512-520.
72. Nioi P., Nguyen T., Sherratt P.J., Pickett C.B. The carboxy-terminal Neh3 domain of Nrf2 is required for transcriptional activation. Mol. Cell. Biol. 2005, 25:10895-10906.
73. Zhang Y., Nicholatos J., Dreier J.R., Ricoult S.J., Widenmaier S.B., Hotamisligil G.S., Kwiatkowski D.J., Manning B.D. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 2014, 513:440-443.
74. Hirotsu Y., Higashi C., Fukutomi T., Katsuoka F., Tsujita T., Yagishita Y., Matsuyama Y., Motohashi H., Uruno A., Yamamoto M. Transcription factor NF-E2-related factor 1 impairs glucose metabolism in mice. Genes Cells 2014, 19:650-665.
75. Oh I.H., Reddy E.P. The myb gene family in cell growth, differentiation and apoptosis. Oncogene 1999, 18:3017-3033.
76. Han W., Ming M., Zhao R., Pi J., Wu C., He Y.Y. Nrf1 CNC-bZIP protein promotes cell survival and nucleotide excision repair through maintaining glutathione homeostasis. J. Biol. Chem. 2012, 287:18788-18795.
77. Murphy P., Kolsto A. Expression of the bZIP transcription factor TCF11 and its potential dimerization partners during development. Mech. Dev. 2000, 97:141-148.
78. Anagnostou S.H., Shepherd P.R. Glucose induces an autocrine activation of the Wnt/beta-catenin pathway in macrophage cell lines. Biochem. J. 2008, 416:211-218.
79. Bar-Nun S. The role of p97/Cdc48p in endoplasmic reticulum-associated degradation: from the immune system to yeast. Curr. Top. Microbiol. Immunol. 2005, 300:95-125.
80. Biswas M., Kwong E.K., Park E., Nagra P., Chan J.Y. Glycogen synthase kinase 3 regulates expression of nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) and inhibits pro-survival function of Nrf1. Exp. Cell Res. 2013, 319:1922-1931.
81. Chepelev N.L., Bennitz J.D., Huang T., McBride S., Willmore W.G. The Nrf1 CNC-bZIP protein is regulated by the proteasome and activated by hypoxia. PLoS ONE 2011, 6:e29167.
82. Nguyen T., Sherratt P.J., Huang H.C., Yang C.S., Pickett C.B. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome. J. Biol. Chem. 2003, 278:4536-4541.
83. Steffen J., Seeger M., Koch A., Krüger E. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol. Cell 2010, 40:147-158.
84. Zhao R., Hou Y., Zhang Q., Woods C.G., Xue P., Fu J., Yarborough K., Guan D., Andersen M.E., Pi J. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes. Environ. Health Perspect. 2012, 120:583-589.
85. Prieschl E.E., Novotny V., Csonga R., Jaksche D., Elbe-Bürger A., Thumb W., Auer M., Stingl G., Baumruker T. A novel splice variant of the transcription factor Nrf1 interacts with the TNF alpha promoter and stimulates transcription. Nucleic Acids Res. 1998, 26:2291-2297.
86. Tsuchiya Y., Taniguchi H., Ito Y., Morita T., Karim M.R., Ohtake N., Fukagai K., Ito T., Okamuro S., Iemura S., Natsume T., Nishida E., Kobayashi A. The casein kinase 2-Nrf1 axis controls the clearance of ubiquitinated proteins by regulating proteasome gene expression. Mol. Cell. Biol. 2013, 33:3461-3472.
87. Shang G., Tang X., Gao P., Guo F., Liu H., Zhao Z., Chen Q., Jiang T., Zhang N., Li H. Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway. J. Nutr. Biochem. 2015, 26:596-606.
88. Rada P., Rojo A.I., Evrard-Todeschi N., Innamorato N.G., Cotte A., Jaworski T., Tobón-Velasco J.C., Devijver H., García-Mayoral M.F., Van Leuven F., Hayes J.D., Bertho G., Cuadrado A. Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis. Mol. Cell. Biol. 2012, 32:3486-3499.
89. Chan J.Y., Kwong M., Lu R., Chang J., Wang B., Yen T.S., Kan Y.W. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J. 1998, 17:1779-1787.
90. Xu Z., Chen L., Leung L., Yen T.S., Lee C., Chan J.Y. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to non-alcoholic steatohepatitis and hepatic neoplasia. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4120-4125.
91. Oh D.H., Rigas D., Cho A., Chan J.Y. Deficiency in the nuclear-related factor erythroid 2 transcription factor (Nrf1) leads to genetic instability. FEBS J. 2012, 279:4121-4130.
92. Sugimoto H., Okada K., Shoda J., Warabi E., Ishige K., Ueda T., Taguchi K., Yanagawa T., Nakahara A., Hyodo I., Ishii T., Yamamoto M. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:G283-G294.
93. Tanaka Y., Aleksunes L.M., Yeager R.L., Gyamfi M.A., Esterly N., Guo G.L., Klaassen C.D. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J. Pharmacol. Exp. Ther. 2008, 325:655-664.
94. Shin S., Wakabayashi J., Yates M.S., Wakabayashi N., Dolan P.M., Aja S., Liby K.T., Sporn M.B., Yamamoto M., Kensler T.W. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Eur. J. Pharmacol. 2009, 620:138-144.
95. Hirotsu Y., Hataya N., Katsuoka F., Yamamoto M. NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1β genes. Mol. Cell. Biol. 2012, 32:2760-2770.
96. Zheng H., Fu J., Xue P., Zhao R., Dong J., Liu D., Yamamoto M., Tong Q., Teng W., Qu W., Zhang Q., Andersen M.E., Pi J. CNC-bZIP protein Nrf1-dependent regulation of glucose-stimulated insulin secretion. Antioxid. Redox Signal. 2015, 22:819-831.
97. Sugii S., Olson P., Sears D.D., Saberi M., Atkins A.R., Barish G.D., Hong S.H., Castro G.L., Yin Y.Q., Nelson M.C., Hsiao G., Greaves D.R., Downes M., Yu R.T., Olefsky J.M., Evans R.M. PPAR gamma activation in adipocytes is sufficient for systemic insulin sensitization. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:22504-22509.
98. Kim S., Sohn I., Ahn J.I., Lee K.H., Lee Y.S. Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004, 340:99-109.
99. Hernandez-Montez E., Pollard S.E., Vauzour D., Jofre-Montseny L., Rota C., Rimbach G., Weinberg P.D., Spencer J.P.E. Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial injury. Biochem. Biophys. Res. Commun. 2006, 346:851-859.
100. Lee C.S., Ho D.V., Chan J.Y. Nuclear factor-erythroid 2-related factor 1 regulates expression of proteasome genes in hepatocytes and protects against endoplasmic reticulum stress and steatosis in mice. FEBS J. 2013, 280:3609-3620.
101. Balasubramanian S., Kanade S., Han B., Eckert R. A proteasome inhibitor-stimulated Nrf1 protein-dependent compensatory increase in proteasome subunit gene expression reduces polycomb group protein level. J. Biol. Chem. 2012, 287:36179-36189.
102. Lee C.S., Lee C., Hu T., Nguyen J.M., Zhang J., Martin M.V., Vawter M.P., Huang E.J., Chan J.Y. Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:8408-8413.
103. Radhakrishnan S.K., Lee C.S., Young P., Beskow A., Chan J.Y., Deshaies R.J. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol. Cell 2010, 38:17-28.
104. Kwong M., Kan Y.W., Chan J.Y. The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts. J. Biol. Chem. 1999, 274:37491-37498.
105. Kobayashi A., Tsukide T., Miyasaka T., Morita T., Mizoroki T., Saito Y., Ihara Y., Takashima A., Noguchi N., Fukamizu A., Hirotsu Y., Ohtsuji M., Katsuoka F., Yamamoto M. Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction. Genes Cells 2011, 16:692-703.
106. Pickering A.M., Linder R.A., Zhang H., Forman H.J., Davies K.J.A. Nrf2-dependent induction of proteasome and Pa28αβ regulator are required for adaptation to oxidative stress. J. Biol. Chem. 2012, 287:10021-10031.
107. Tsakiri E.N., Sykiotis G.P., Papassideri I.S., Terpos E., Dimopoulos M.A., Gorgoulis V.G., Bohmann D., Trougakos I.P. Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging. Aging Cell 2013, 12:802-813.
108. Tonoki A., Kuranaga E., Tomioka T., Hamazaki J., Murata S., Tanaka K., Miura M. Genetic evidence linking age-dependent attenuation of the 26S proteasome with the aging process. Mol. Cell. Biol. 2008, 29:1095-1106.
109. Harding H.P., Zhang Y., Zeng H., Novoa I., Lu P.D., Calfon M., Sadri N., Yun C., Popko B., Paules R., Stojdl D.F., Bell J.C., Hettmann T., Leiden J.M., Ron D. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 2003, 11:619-633.
110. Ide T., Tsutsui H., Kinugawa S., Utsumi H., Kang D., Hattori N., Uchida K., Arimura Ki, Egashira K., Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ. Res. 1999, 85:357-363.
111. 2+)/ERK1/2 signaling pathway in human skin fibroblast cells. BMB Rep. 2013, 46:258-263.
112. Chepelev N.L., Zhang H., Liu H., McBride S., Seal A.J., Morgan T.E., Finch C.E., Willmore W.G., Davies K.J., Forman H.J. Competition of nuclear factor-erythroid 2 factors related transcription factor isoforms, Nrf1 and Nrf2, in antioxidant enzyme induction. Redox Biol. 2013, 1:183-189.
113. Aiken C.T., Kaake R.M., Wang X., Huang L. Oxidative stress-mediated regulation of proteasome complexes. Mol. Cell. Proteomics 2011, 10(R110.006924):1-11.
114. Jung T., Hohn A., Grune T. The proteasome and the degradation of oxidized proteins: part II - protein oxidation and proteasomal degradation. Redox Biol. 2014, 2:99-104.
115. Jones D.P., Go Y.M. Redox compartmentalization and cellular stress. Diabetes Obes. Metab. 2010, 12:116-125.
116. Digaleh H., Kiaei M., Khodagholi F. Nrf2 and Nrf1 signaling and ER stress crosstalk: implication for proteasomal degradation and autophagy. Cell. Mol. Life Sci. 2013, 70:4681-4694.
117. Ho D.V., Chan J.Y. Induction of Herpud1 expression by ER stress is regulated by Nrf1. FEBS Lett. 2015, 589:615-620.
118. Jang Y., Sharkis S.J. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood 2007, 110:3056-3063.
119. Chai X., Li D., Cao X., Zhang Y., Mu J., Lu W., Xiao X., Li C., Meng J., Chen J., Li Q., Wang J., Meng A., Zhao M. ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice. Sci. Rep. 2015, 5.
120. Chen C., Liu Y., Ikenoue T., Guan K.L., Liu Y., Zheng P. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 2008, 205:2397-2408.
121. Ufer C., Wang C.C., Borchert A., Heydeck D., Kuhn H. Redox control in mammalian embryo development. Antioxid. Redox Signal. 2010, 13:833-875.
122. Kim J., Xing W., Wergedal J., Chan J.Y., Mohan S. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice. Physiol. Genomics 2010, 40:100-110.
123. Narayanan K., Ramachandran A., Peterson M.C., Hao J., Kolsto A.B., Friedman A.D., George A. The CCAAT enhancer-binding protein (C/EBP)beta and Nrf1 interact to regulate dentin sialophosphoprotein (DSPP) gene expression during odontoblast differentiation. J. Biol. Chem. 2004, 279:45423-45432.
124. Novotny V., Prieschl E.E., Csonga R., Fabjani G., Baumruker T. Nrf1 in a complex with fosB, c-jun, junD and ATF2 forms the AP1 component at the TNF alpha promoter in stimulated mast cells. Nucleic Acids Res. 1998, 26:5480-5485.
125. Berg D.T., Gupta A., Richardson M.A., O'Brien L.A., Calnek D., Grinnell B.W. Negative regulation of inducible nitric-oxide synthase expression mediated through transforming growth factor-beta-dependent modulation of transcription factor TCF11. J. Biol. Chem. 2007, 282:36837-36844.
126. Ma Q., Battelli L., Hubbs A.F. Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. Am. J. Pathol. 2006, 168:1960-1974.
127. Wu J.L., Lin Y.S., Yang C.C., Lin Y.J., Wu S.F., Lin Y.T., Huang C.F. Repression of Nrf1-mediated transactivation by MCRS2. BMC Cell Biol. 2009, 10:9.
128. Nojima K., Ken S., Hironori U., Naru B., Hiroshi I., Hiromi R. Analysis of hepatic gene expression profile in a spontaneous mouse model of type 2 diabetes under a high sucrose diet. Endocr. J. 2014, 60:261-274.
129. Vock C., Gleissner M., Klapper M., Doring F. Identification of palmitate-regulated genes in HepG2 cells by applying microarray analysis. Biochim. Biophys. Acta 2007, 1770:1283-1288.
130. Tomita K., Azuma T., Kitamura N., Tamiya G., Ando S. Leptin deficiency enhances sensitivity of rats to alcoholic steatohepatitis through suppression of metallothionein. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G1078-G1085.
131. Hayes J.D., McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 2001, 174:103-113.
132. Song M.O., Mattie M.D., Lee C.H., Freedman J.H. The role of Nrf1 and Nrf2 in the regulation of copper-responsive transcription. Exp. Cell Res. 2014, 322:39-50.
133. Crawford D.R., Leahy K.P., Wang Y., Schools G.P., Kochheiser J.C., Davies K.J.A. Oxidative stress induces the levels of a MafG homolog in hamster HA-1 cells. Free Radic. Biol. Med. 1996, 21:521-525.
134. Zhao R., Hou Y., Zhang Q., Woods C.G., Xue P., Fu J., Yarborough K., Guan D., Andersen M.E., Pi J. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes 2012, 120:583-589.
135. Igarashi K., Kataoka K., Itoh K., Hayashi N., Nishizawa M., Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature 1994, 367:568-572.
136. Kataoka K., Igarashi K., Itoh K., Fujiwara K.T., Noda M., Yamamoto M., Nishizawa M. Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Mol. Cell. Biol. 1995, 15:2180-2190.
137. Marini M.G., Asunis I., Chan K., Chan J.Y., Kan Y.W., Porcu L., Cao A., Moi P. Cloning MafF by recognition site screening with the NFE2 tandem repeat of HS2: analysis of its role in globin and GCSl genes regulation. Blood Cells Mol. Dis. 2002, 29:145-158.
138. Yamazaki H., Katsuoka F., Motohashi H., Engel J.D., Yamamoto M. Embryonic lethality and fetal liver apoptosis in mice lacking all three small Maf proteins. Mol. Cell. Biol. 2012, 32:808-816.
139. Nguyen T., Huang H.C., Pickett C.B. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 2000, 275:15466-15473.
140. Kannan M.B., Solovieva V., Blank V. The small MAF transcription factors MAFF, MAFG and MAFK: current knowledge and perspectives. Biochim. Biophys. Acta 2012, 1823:1841-1846.
141. Suzuki T. The cytoplasmic peptide:N-glycanase (Ngly1)-basic science encounters a human genetic disorder. J. Biochem. 2015, 157:23-34.
142. Afonyushkin T., Oskolkova O.V., Philippova M., Resink T.J., Erne P., Binder B.R., Bochkov V.N. Oxidized phospholipids regulate expression of ATF4 and VEGF in endothelial cells via Nrf2-dependent mechanism: Novel point of convergence between electrophilic and unfolded response pathways. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1007-1013.
143. Pati D., Habibi H.R., Gedamu L. Inhibition of zinc-induced metallothionein mRNA accumulation by gonadotropin-releasing hormone in human hepatocarcinoma cell line HepG2. Eur. J. Biochem. 1996, 242:36-40.
144. Bustin S.A., Benes V., Garson J.A., Hellemans J., Huggett J., Kubista M., Mueller R., Nolan T., Pfaffl M.W., Shipley G.L., Vandesompele J., Wittwer C.T. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 2009, 55:611-622.
145. Lau A., Tian W., Whitman S.A., Zhang D.D. The predicted molecular weight of Nrf2: it is what it is not. Antioxid. Redox Signal. 2013, 18:91-93.